|
FLJ36031 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.433800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.154000E-02 |
| Normal-vs-Stage2 |
4.441700E-02 |
| Normal-vs-Stage3 |
3.710300E-02 |
| Normal-vs-Stage4 |
7.924100E-02 |
| Stage1-vs-Stage2 |
4.408800E-01 |
| Stage1-vs-Stage3 |
4.703200E-01 |
| Stage1-vs-Stage4 |
8.203800E-01 |
| Stage2-vs-Stage3 |
7.849200E-01 |
| Stage2-vs-Stage4 |
5.814000E-01 |
| Stage3-vs-Stage4 |
6.955400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.222620E-01 |
| Normal-vs-AfricanAmerican |
2.310200E-01 |
| Normal-vs-Asian |
2.404500E-02 |
| Caucasian-vs-AfricanAmerican |
9.438400E-01 |
| Caucasian-vs-Asian |
1.313640E-01 |
| AfricanAmerican-vs-Asian |
3.507000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.859800E-03 |
| Normal-vs-Female |
8.002500E-02 |
| Male-vs-Female |
2.779600E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.044400E-01 |
| Normal-vs-Age(41-60Yrs) |
1.009560E-02 |
| Normal-vs-Age(61-80Yrs) |
1.631650E-02 |
| Normal-vs-Age(81-100Yrs) |
8.414000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.160200E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.567800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.737600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.690200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.656400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.797000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.652600E-01 |
| Classical-VS-Follicular |
2.11197725974444E-12 |
| Classical-VS-Other |
2.454800E-01 |
| Classical-VS-Normal |
2.565600E-01 |
| Tall-VS-Follicular |
5.025900E-04 |
| Tall-VS-Other |
2.197400E-01 |
| Tall-VS-Normal |
1.643440E-01 |
| Follicular-VS-Other |
6.451200E-01 |
| Follicular-VS-Normal |
2.28409999999402E-05 |
| Other-VS-Normal |
1.499990E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.922700E-03 |
| Normal-vs-N1 |
7.167800E-01 |
| N0-vs-N1 |
1.794800E-01 |
|
|
